Recent developments in cancer treatment continue to present optimism for patients. Investigators are intensely exploring innovative approaches, including harnessing the immune system, targeted agents, and precision healthcare . A major research published this week highlights the efficacy of a experimental drug in combating late-stage NSCLC. Further